Framework for the supply of Radiopharmaceuticals and Related Consumables - 2023
Estimated value
—
goods
Awarded value
—
Suppliers
6
3 SME
Lots
2
6 awarded
Published
12 Dec 2023
Description
HealthTrust Europe (HTE) is seeking to establish a multi-Lot framework agreement for the supply of Radiopharmaceuticals, which are sterile and non-sterile radioactive drugs used in nuclear medicine procedures to diagnose, monitor, and treat diseases.
Scope
- Reference
- ocds-h6vhtk-03cfab
- Commercial tool
- Standalone contract
- Contract dates
2 extensions of 12 months each
- Main category
- goods
- CPV classifications
- 093440003314000033600000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | 60 | quality | — |
| Social Value | 10 | quality | — |
| — | 30 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 6 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Agreement with Access Pricing via Direct Award for the Supply of Radiopharmaceuticals Components and Consumables | £50.0m | cancelled |
| 2 | Agreement with Access Pricing via Direct Award for the Supply of Patient Specific Radiopharmaceuticals | £50.0m | cancelled |